Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Neurology|June 17, 2016
And why not thrombolysis in the ambulance (at least for some)?Gilad Rosenberg, Israel SteinerBritish Journal of Clinical Pharmacology|June 21, 2005
Clinical pharmacology of DP-b99 in healthy volunteers: first administration to humansGilad Rosenberg, Itzchak Angel, Alex KozakJournal of Human Lactation : Official Journal of International Lactation Consultant Association|March 22, 2021
Tandem Breastfeeding and Human Milk Macronutrients: A Prospective Observational StudyGilad Rosenberg, Laurence Mangel, Dror Mandel, et al.European Journal of Clinical Pharmacology|November 10, 2018
The impact of R353Q genetic polymorphism in coagulation factor VII on the initial anticoagulant effect exerted by warfarinChanan Shaul, Simcha Blotnick, Liat Deutsch, et al.International Journal of Stroke : Official Journal of the International Stroke Society|June 8, 2011
The Membrane-Activated Chelator Stroke Intervention (MACSI) Trial of DP-b99 in acute ischemic stroke: a randomized, double-blind, placebo-controlled, multinational pivotal phase III studyGilad Rosenberg, Natan Bornstein, Hans-Christoph Diener, et al.Stroke|April 12, 2008
DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic strokeHans-Christoph Diener, Dietmar Schneider, Yair Lampl, et al.Stroke|February 9, 2013
Results of Membrane-Activated Chelator Stroke Intervention randomized trial of DP-b99 in acute ischemic strokeKennedy R Lees, Natan Bornstein, Hans-Christoph Diener, et al.Pageof 1